Colfax Co. (NYSE:CFX) saw unusually large options trading activity on Monday. Stock investors bought 14,185 put options on the stock. This represents an increase of 1,427% compared to the typical daily volume of 929 put options.
Several equities analysts have recently commented on CFX shares. Citigroup increased their target price on Colfax from $35.00 to $41.00 in a research note on Monday, February 22nd. KeyCorp boosted their target price on shares of Colfax from $47.00 to $57.00 and gave the company an “overweight” rating in a research note on Thursday, March 18th. Morgan Stanley increased their target price on shares of Colfax from $45.00 to $47.00 and gave the stock an “equal weight” rating in a report on Friday. TheStreet raised shares of Colfax from a “c” rating to a “b-” rating in a report on Monday, February 22nd. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Colfax from $53.00 to $54.00 and gave the stock a “hold” rating in a research note on Friday, March 12th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $40.58.
In other news, CEO Matthew L. Trerotola sold 6,057 shares of Colfax stock in a transaction dated Thursday, February 25th. The shares were sold at an average price of $46.01, for a total transaction of $278,682.57. Following the completion of the sale, the chief executive officer now directly owns 233,699 shares in the company, valued at $10,752,490.99. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Shyam Kambeyanda sold 1,850 shares of the firm’s stock in a transaction dated Thursday, February 25th. The stock was sold at an average price of $46.01, for a total value of $85,118.50. Following the completion of the sale, the executive vice president now directly owns 62,389 shares in the company, valued at $2,870,517.89. The disclosure for this sale can be found here. Insiders have sold a total of 40,524 shares of company stock worth $1,886,484 over the last 90 days. Insiders own 12.00% of the company’s stock.
Shares of CFX stock opened at $43.66 on Tuesday. Colfax has a 1 year low of $22.30 and a 1 year high of $50.26. The firm has a market capitalization of $5.91 billion, a PE ratio of -873.20, a price-to-earnings-growth ratio of 2.61 and a beta of 2.15. The stock has a fifty day moving average of $44.85 and a two-hundred day moving average of $39.66. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.96 and a current ratio of 1.64.
Colfax (NYSE:CFX) last announced its earnings results on Thursday, April 29th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.05. Colfax had a negative net margin of 0.24% and a positive return on equity of 6.04%. Equities research analysts predict that Colfax will post 1.38 earnings per share for the current fiscal year.
Colfax Company Profile
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment.
Featured Article: What is operating income?
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.